Hospital based study to evaluate subclinical hypothyroidism in post-menopausal women

Shruthi Kamal V.; Rajesh S.; Reshma S.

doi:10.18203/2349-2902.isj20175886

Authors

Shruthi Kamal V. Department of General Surgery, Saveetha Medical College and Hospital, Thandalam, Chennai, Tamil Nadu, India
Rajesh S. Department of General Surgery, Saveetha Medical College and Hospital, Thandalam, Chennai, Tamil Nadu, India
Reshma S. Department of General Surgery, Saveetha Medical College and Hospital, Thandalam, Chennai, Tamil Nadu, India

DOI:

https://doi.org/10.18203/2349-2902.isj20175886

Keywords:

Chemiluminescence immunoassay, Postmenopausal women, Subclinical hypothyroidism, TSH

Abstract

Background: Very few studies have assessed prevalence of subclinical hypothyroidism in postmenopausal women. In this study, we aimed to assess the prevalence of subclinical hypothyroidism in postmenopausal women.

Methods: Hospital based cross - sectional study carried out at Saveetha Medical College, Chennai, during the period of August 2016 to October 2016. Seventy-five women in General Surgery ward/OPD were included in the study. Subjects included in the study were postmenopausal age group between 45 to 85 years, provided they fulfilled inclusion and exclusion criteria. History was noted, serum Thyroid function test was done. Results were noted and analyzed.

Results: Out of 75 subjects, 21.3% of postmenopausal women were having subclinical hypothyroidism.

Conclusions: Prevalence of Subclinical hypothyroidism is high among postmenopausal women, which leads to overt hypothyroidism. Therefore, routine screening and treatment of this condition is must among postmenopausal women to prevent complications of subclinical hypothyroidism.

Metrics

Metrics Loading ...

References

Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. Jama. 2002 Jul 17;288(3):321-33.

Kronenberg F. Hot Flashes: Epidemiology and Physiology. Ann NY Acad Sci. 1990;592:52-86.

Polo- Kantola P, Saaresranta T, Polo O. Aetiology and treatment of sleep disturbances during perimenopause and postmenopause. CNS Drugs. 2001;15:445-52.

Hernández VM, Córdova PN, Zárate A, Basurto L, Manuel AL, Ruiz M, Vargas C, Vargas A. Hypothyroidism associated to menopause symptoms worsening change with thyroid substitution therapy. Ginecologia y obstetricia de Mexico. 2008;76(10):571-5.

Zigman JM, Cohen SE, Garber JR. Impact of thyroxine- binding globulin on thyroid hormone economy during pregnancy. Thyroid. 2003;13:1169-74.

Aoki Y, Belin RM, Chickener R, Jeffries R, Phillips L, Mahaffey KR. Serum TSH and total T4 in the United States population and their association with participant characteristics: National Heuurberg P. Narroun NH, Lalth and Nutrition Examination Survey. Thyroid. 2007;17(1050-7256):1211-23.

Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988-1994): National Health and Nutrition Examination Survey. J Clin Endocrinol Metab. 2002;87(2):489-99.

Rosario PW, Bessa B, Valado MM, Purisch S. Natural history of mild subclinical hypothyroidism: Prognostic volume of ultrasound. Thyroid Jan. 2009;9:12.

Olson AF. Subclinical hypothyroidism in women: Will screening and early detection reduce hyperlipidemia? The internet Journal of advanced nursing Practice. 2001:5(1).

Meier C, Staub JJ, Roth CB, Guglielmetti M, Kunz M, Miserez AR, et al. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). J Clin Endocrinol Metab. 2001;86(10):4860-6.

National committee for clinical laboratory standards. procedures for the handling and processing of blood specimens; approved guideline- 3rd Ed. NCCLS Document H18-A3; Wayne [PA]. NCCLS; 2004.

Kaplan LA, Pesce AJ. Clinical chemistry: Theory analysis, correlation; Missouri, Mosby Publishers. 2003;4:836-53.

Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160:526-34.

Empson M, Flood V, Ma G, Eastman CJ, Mitchell P. Prevalence of thyroid disease in an older Australian Population. Int Med J. 2007;37:448-55.

O’ Leary PC, Feddema PH, Michelangeli VP, Leedman PJ, Chew GT, Knuiman M, et al. Investigations of thyroid Hormones and antibodies based on a community health survey: the Busselton thyroid study. Clin Endocrinol. 2006;64:97-104.

Pearce EN. Thyroid dysfunction in Peri- and Post-menopausal women. Menopause Int Mar. 2007;13(1):8-13.

Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Int Med. 2000;132(4):270-8.

Diez JJ, Iglesias P. spontaneous subclinical hypothyroidism in patients older than 55 years: an analysis of natural course and risk factors for the development of overt thyroid failure. J Clin Endocrinol Metab. 2004; 89: 4890-7.

Parle JV, Maisonneuve P, Sheppard MC, Boyle P, Franklyn JA. Prediction of all- cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10 years cohort study. Lancet. 2001;358:861-5.

Parle JV, Franklyn JA, Cross KW, Jones SC, Sheppard MC. Prevalence and Follow- up of abnormal thyrotropin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol. 1991;34:77-83.